Phase 1 Trial of SYNC-T - Immunotherapy for Patients With Advanced/Metastatic Solid Tumors

Abroad (travel likely)RecruitingPHASE1

Conditions

Metastatic Cancer · Metastatic Breast Cancer · Metastatic Lung Cancer · Solid Tumor · Cancer

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Hospital Diomed, Mexico City, Mexico
Contact: Study coordinator (Jason Williams, MD) · dr@williamscancerinstitute.com · 1-954-530-4606

Study leads

Jason Williams, MD
Principal Investigator
Williams Cancer Institute

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

First-in-Human Study of Mutant-selective PI3Kα Inhibitor, RLY-2608, as a Single Agent in Patients With Advanced Solid Tumors and in Combination With Endocrine Therapy +/- a CDK4/6 or CDK4 Inhibitor in Patients With Advanced Solid Tumors or Advanced Breast Cancer

PIK3CA Mutation · Solid Tumor, Adult · HER2-negative Breast Cancer

Abroad (travel likely)RecruitingPHASE1

Tucson, United States · San Diego, United States

A Study to Find a Suitable Dose of ASP5834 in Adults With Solid Tumors

Solid Tumor · Non-Small-Cell Lung Cancer · Pancreatic Ductal Adenocarcinoma

Abroad (travel likely)RecruitingPHASE1

Santa Monica, United States · Atlanta, United States

Phase I Study of Tolododekin Alfa (ANK-101) in Advanced Solid Tumors

Advanced Solid Tumor · Cutaneous Tumor · Subcutaneous Tumor

Abroad (travel likely)RecruitingPHASE1

Bethesda, United States · Boston, United States

Bortezomib Plus Cisplatin in Recurrent or Metastatic Breast Cancer

Metastatic Breast Cancer · Recurrent Breast Cancer

Abroad (travel likely)RecruitingPHASE1

Guangzhou, China